Regadenoson is safe, effective for use in heart transplant patients, study finds
Sunday, March 14, 2010 - 15:21
in Health & Medicine
The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a new study. Researchers say the 25 patients in the study did not experience adverse side effects such as abnormally low blood pressure or slow heart beat when regadenoson was used during the stress test.
Read the whole article on Science Daily
More from Science Daily
Related
- Regadenoson is safe, effective for use in heart transplant patientsSun, 14 Mar 2010, 10:16:41 EDT
- Heart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades Mon, 24 Oct 2011, 12:36:06 EDT
- Heart test found safe for pre-transplant kidney patientsThu, 15 Oct 2009, 18:26:25 EDT
- Heart medication best at bedtime, study revealsMon, 9 May 2011, 16:34:41 EDT
- Non-cardiac surgery: Safe for patients with heart deviceFri, 15 Apr 2011, 14:03:53 EDT